Latest news
- Home
- Press Room
- Latest News
Genomics plays a vital role in driving Québec's economic future. That is why Génome Québec aims at advancing knowledge in genomics by funding major research projects. In this section, you will discover all the latest achievements in the field of genomics.
Canadian researchers lead groundbreaking discovery in deadly childhood cancer
Dec. 11, 2013
A new study by Canadian researchers may pave the way for more effective treatment of an aggressive and deadly type of brain tumour, known as ETMR/ETANTR. The tumour, which is seen only in children under four, is almost always fatal, despite aggressive treatment. The study proposes a new model for how this brain tumour develops and suggests possible targets to investigate for novel therapies.
UCB Canada supports efforts to identify personalized treatment approach for drug-resistant epilepsy
Dec. 10, 2013
Genome Canada and Génome Québec are pleased to announce UCB Canada Inc.’s contribution to a four-year study aimed at developing a personalized medicine approach to the early diagnosis of various types of epilepsy.
COPD patients starting to breathe easier
Dec. 4, 2013
Two BC researchers have combined forces to develop a blood test that will identify patients at high risk for Chronic Obstructive Pulmonary Disease (COPD) lung attacks. This much needed test will help medical professionals provide better treatment and ultimately lead to patients with fewer attacks, and reduced hospitalization and emergency visits.
Fred Sanger, the quiet giant of genomics, dies at the age of 95
Nov. 25, 2013
Génome Québec pays tribute to Fred Sanger, who died on Tuesday 19 November 2013, at the age of 95. He was the quiet giant of genomics, the father of an area of science that we will explore for decades to come.
Don't miss the next Rendez-Vous Génome Québec
Nov. 12, 2013
Thursday November 14, don't miss the next Rendez-Vous Génome Québec on the theme: "Improving Genomics through Collaboration and Innovation".
NGS academic and industry presentation will be featured from 8:00 AM to 4:30 PM. Lunch and coffee breaks are included and the day will conclude with a poster session and a social event with snacks and beverages.
For more information: http://gqinnovationcenter.com/events/rendezVous.aspx?l=e#1
This event will take place at the McGill University New Residence Hall
New Residence Hall, 3625 Parc Avenue, Montréal
New study to determine risk of Down syndrome
Nov. 4, 2013
A team of clinical researchers led by CHU de Québec and Université Laval has received CAN$10.5 million from Génome Québec, Genome Canada, CIHR, Genome Alberta and other partners to recruit 5,600 pregnant women in Canada to study the potential of using DNA sequencing alone or in a contingent model with first trimester serum markers as a non-invasive method for detecting birth defects. The four marker first trimester serum quadruple screen,1T-Quad (PAPP-A, Free beta hCG, AFP and PIGF) provided by PerkinElmer will be used by researchers to validate its use in a contingent model where women identified by the 1T-Quad screen as having an increased risk of fetal aneuploidy undergo analysis of cell-free circulating fetal DNA from a standard blood draw to better estimate their risk of Down syndrome or other trisomy.
A first! A presentation in French on TED.com!
Oct. 29, 2013
Pr. Mohamed Hijri's excellent presentation at the TEDxUdeM conference held in Montréal on March 11, 2012 caught the attention of the persons responsible for TED conferences in the US. As of today, his presentation on a microscopic mushroom is online in its French original version on TED.com (English subtitles).
Dawn of a new era for children: Introducing Canada’s first integrated clinical genomic centre in pediatrics
Oct. 21, 2013
Montréal, October 21, 2013 – Dr. Fabrice Brunet, Chief Executive Officer at Sainte-Justine UHC, and Marc LePage, President and CEO of Génome Québec, are extremely proud to announce the launch of Canada’s first integrated clinical genomic centre in pediatrics, an initiative currently at the forefront of global efforts in this area. “We are honoured to have the opportunity to make this partnership a reality in the presence of the Québec Premier, Pauline Marois, and Dr. Réjean Hébert, Minister of Health and Social Services and Minister responsible for Seniors,” said Messrs. Brunet and LePage at the official launch.
Génome Québec welcomes National Research and Innovation Policy
Oct. 16, 2013
Montréal, October 16, 2013 – Génome Québec welcomes the National Research and Innovation Policy (PNRI) announced by the Québec Government. The policy is a major step forward in the government’s vision and support of research and innovation, since it now places the sector at the centre of its economic strategy.
New Discoveries for Cancer Risk
Oct. 9, 2013
Researchers Worldwide Take Part
in one of History’s Largest Scientific Consortia
Hundreds of researchers from North America, Europe, Australia and Asia have joined together in a consortium to identify the genetic basis of the five most common forms of cancer – breast, prostate, lung, ovarian and colorectal. The group, called the OncoArray Consortium, developed a new customized genotyping tool – the OncoArray – manufactured by the U.S. genomics firm Illumina, Inc.